Jpmorgan Chase & CO Pro Phase Labs, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRPH
# of Institutions
31Shares Held
1.66MCall Options Held
500Put Options Held
6K-
Vanguard Group Inc Valley Forge, PA656KShares$505,0790.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny215KShares$165,6340.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL179KShares$137,8640.0% of portfolio
-
Geode Capital Management, LLC Boston, MA161KShares$123,7650.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL82.9KShares$63,8570.11% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $12.3M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...